Abstract
Despite increases in injection drug use, depression, and fatal overdose among young people (aged 18–30) during the last 15–20 years, and despite literature among other populations finding relationships between various types of stigma and mental health outcomes, to date, there have been no studies examining the relationship between substance use-related stigma and depression among young people who inject drugs (PWID), specifically. The present study examined baseline data from a longitudinal study of young (18–30-year-old) PWID and their risk network members of any age. Multiple linear regression was used to explore the relationship between substance use-related stigma and depression. Stigma was measured both as a composite score of all stigma types/domains, and separately as enacted, anticipated, and internalized stigma. Results are compared for the full sample and for the subsample of young PWID (N = 166). Greater levels of the composite measure of all stigma types were associated with greater levels of depression among both samples. While each of the three domains of stigma, measured separately, significantly predicted greater levels of depression among the full sample, only enacted stigma and anticipated stigma were significantly associated with depression among the subsample of young PWID. These findings suggest that to address mental health challenges among young PWID, in addition to providing mental health support and treatment, intervention efforts should focus on the direct reduction of stigma among the general population. Since internalized stigma does not significantly predict depression, working with young PWID to address internalized stigma is unlikely to be effective.
Similar content being viewed by others
References
Adams, M., Sionean, C., Broz, D., Lewis, R., & Wejnert, C. (2020). Serious mental illness among young people who inject drugs: An assessment of injection risks and healthcare use. The Journal of Infectious Diseases, 222(Supplement_5), S401–S409.
Ahmed, A., Saqlain, M., Umair, M. M., Hashmi, F. K., Saeed, H., Amer, M., Blebil, A. Q., & Dujaili, J. A. (2021). Stigma, social support, illicit drug use, and other predictors of anxiety and depression among HIV/AIDS patients in Pakistan: A cross-sectional study. Frontiers in Public Health, 9, 745545.
Akdağ, E. M., Kotan, V. O., Kose, S., Tıkır, B., Aydemir, M. Ç., Okay, İ. T., Göka, E., & Özkaya, G. (2018). The relationship between internalized stigma and treatment motivation, perceived social support, depression and anxiety levels in opioid use disorder. Psychiatry and Clinical Psychopharmacology, 28(4), 394–401.
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994). Screening for depression in well older adults: Evaluation of a short form of the CES-D. American Journal of Preventive Medicine, 10(2), 77–84.
Bartoli, F., Carrà, G., Brambilla, G., Carretta, D., Crocamo, C., Neufeind, J., et al. (2014). Association between depression and non-fatal overdoses among drug users: A systematic review and meta-analysis. Drug and alcohol dependence, 134, 12–21.
Bayat, A. H., Mohammadi, R., Moradi-Joo, M., Bayani, A., Ahounbar, E., Higgs, P., Hemmat, M., Haghgoo, A., & Armoon, B. (2020). HIV and drug related stigma and risk-taking behaviors among people who inject drugs: a systematic review and meta-analysis. Journal of Addictive Diseases, 38(1), 71–83.
Birtel, M. D., Wood, L., & Kempa, N. J. (2017). Stigma and social support in substance abuse: Implications for mental health and well-being. Psychiatry Research, 252, 1–8.
Björgvinsson, T., Kertz, S. J., Bigda-Peyton, J. S., McCoy, K. L., & Aderka, I. M. (2013). Psychometric properties of the CES-D-10 in a psychiatric sample. Assessment, 20(4), 429–436.
Boodram, B., Mackesy-Amiti, M. E., Khanna, A., Brickman, B., Dahari, H., & Ozik, J. (2022). People who inject drugs in metropolitan Chicago: A meta-analysis of data from 1997-2017 to inform interventions and computational modeling toward hepatitis C microelimination. PLOS One, 17(1), e0248850.
Boodram, B., Mackesy-Amiti, M. E., & Latkin, C. (2015). The role of social networks and geography on risky injection behaviors of young persons who inject drugs. Drug and Alcohol Dependence, 154, 229–235.
Brienza, R. S., Stein, M. D., Chen, M. H., Gogineni, A., Sobota, M., Maksad, J., Hu, P., & Clarke, J. (2000). Depression among needle exchange program and methadone maintenance clients. Journal of Substance Abuse Treatment, 18(4), 331–337.
Cama, E., Brener, L., Wilson, H., & von Hippel, C. (2016). Internalized stigma among people who inject drugs. Substance Use & Misuse, 51(12), 1664–1668.
Centers for Disease Control and Prevention. (2021). Drug overdose deaths in the US top 100,000 annually. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
Conner, K. R., Pinquart, M., & Duberstein, P. R. (2008). Meta-analysis of depression and substance use and impairment among intravenous drug users (IDUs). Addiction, 103(4), 524–534.
Daughters, S. B., Braun, A. R., Sargeant, M. N., Reynolds, E. K., Hopko, D. R., Blanco, C., & Lejuez, C. W. (2008). Effectiveness of a brief behavioral treatment for inner-city illicit drug users with elevated depressive symptoms: the life enhancement treatment for substance use (LETS Act!). Journal of Clinical Psychiatry, 69(1), 122.
Earnshaw, V. A. (2020). Stigma and substance use disorders: A clinical, research, and advocacy agenda. American Psychologist, 75(9), 1300.
Ettman, C. K., Abdalla, S. M., Cohen, G. H., Sampson, L., Vivier, P. M., & Galea, S. (2020). Prevalence of depression symptoms in US adults before and during the COVID-19 pandemic. JAMA Network Ppen, 3(9), e2019686–e2019686.
Ettman, C. K., Cohen, G. H., Abdalla, S. M., Sampson, L., Trinquart, L., Castrucci, B. C., Bork, R. H., Clark, M. A., Wilson, I., Vivier, P. M., & Galea, S. (2022). Persistent depressive symptoms during COVID-19: A national, population-representative, longitudinal study of US adults. The Lancet Regional Health-Americas, 5, 100091.
Ettman, C. K., Cohen, G. H., & Galea, S. (2020). Is wealth associated with depressive symptoms in the United States? Annals of Epidemiology, 43, 25–31.
Fong, C., Mateu-Gelabert, P., Ciervo, C., Eckhardt, B., Aponte-Melendez, Y., Kapadia, S., & Marks, K. (2021). Medical provider stigma experienced by people who use drugs (MPS-PWUD): Development and validation of a scale among people who currently inject drugs in New York City. Drug and alcohol dependence, 221, 108589.
Golden, J., O'Dwyer, A. M., & Conroy, R. M. (2005). Depression and anxiety in patients with hepatitis C: Prevalence, detection rates and risk factors. General Hospital Psychiatry, 27(6), 431–438.
Goodwin, R. D., Dierker, L. C., Wu, M., Galea, S., Hoven, C. W., & Weinberger, A. H. (2022). Trends in US depression prevalence from 2015 to 2020: The widening treatment gap. American Journal of Preventive Medicine, 63(5), 726–733.
Hatzenbuehler, M. L., Phelan, J. C., & Link, B. G. (2013). Stigma as a fundamental cause of population health inequalities. American Journal of Public Health, 103(5), 813–821.
Horwitz, A. G., Berona, J., Czyz, E. K., Yeguez, C. E., & King, C. A. (2017). Positive and negative expectations of hopelessness as longitudinal predictors of depression, suicidal ideation, and suicidal behavior in high-risk adolescents. Suicide and Life-Threatening Behavior, 47(2), 168–176.
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., & Abdollahpour, I. (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 392(10159), 1789–1858.
Kawachi, I., & Berkman, L. F. (2001). Social ties and mental health. Journal of Urban Health, 78, 458–467.
Latkin, C., Davey-Rothwell, M., Yang, J. Y., & Crawford, N. (2013). The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. Journal of Urban Health, 90, 147–156.
Latkin, C., Srikrishnan, A. K., Yang, C., Johnson, S., Solomon, S. S., Kumar, S., Celentano, D. D., & Solomon, S. (2010). The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug and Alcohol Dependence, 110(3), 221–227.
Lewinsohn, P. M., Rohde, P., & Seeley, J. R. (1998). Major depressive disorder in older adolescents: Prevalence, risk factors, and clinical implications. Clinical Psychology Review, 18(7), 765–794.
Li, F., Luo, S., Mu, W., Li, Y., Ye, L., Zheng, X., Xu, B., Ding, Y., Ling, P., Zhou, M., & Chen, X. (2021). Effects of sources of social support and resilience on the mental health of different age groups during the COVID-19 pandemic. BMC Psychiatry, 21, 1–14.
Link, B. G., Struening, E. L., Neese-Todd, S., Asmussen, S., & Phelan, J. C. (2001). Stigma as a barrier to recovery: The consequences of stigma for the self-esteem of people with mental illnesses. Psychiatric Services, 52(12), 1621–1626.
Mandell, W., Kim, J., Latkin, C., & Suh, T. (1999). Depressive symptoms, drug network, and their synergistic effect on needle-sharing behavior among street injection drug users. The American Journal of Drug and Alcohol Abuse, 25(1), 117–127.
Miller-Lloyd, L., Landry, J., Macmadu, A., Allard, I., & Waxman, M. (2020). Barriers to healthcare for people who inject drugs: A survey at a syringe exchange program. Substance Use & Misuse, 55(6), 896–899.
Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6).
Muncan, B., Walters, S. M., Ezell, J., & Ompad, D. C. (2020). “They look at us like junkies”: Influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City. Harm Reduction Journal, 17, 1–9.
National Academies of Sciences, Engineering, and Medicine. (2016). Ending discrimination against people with mental and substance use disorders: The evidence for stigma change. National Academies Press.
Pachankis, J. E. (2007). The psychological implications of concealing a stigma: A cognitive-affective-behavioral model. Psychological Bulletin, 133(2), 328.
Perdue, T., Hagan, H., Thiede, H., & Valleroy, L. (2003). Depression and HIV risk behavior among Seattle-area injection drug users and young men who have sex with men. AIDS Education and Prevention, 15(1), 81–92.
Raiker, N., Aouthmany, M., & Ezra, N. (2016). Dermatologic signs and symptoms of substance abuse. Journal of Clinical & Experimental Dermatology Research, 7(2), 337.
Roy, É., Arruda, N., Bruneau, J., & Jutras-Aswad, D. (2016). Epidemiology of injection drug use: New trends and prominent issues. The Canadian Journal of Psychiatry, 61(3), 136–144.
Sherr, L., Clucas, C., Harding, R., Sibley, E., & Catalan, J. (2011). HIV and depression–a systematic review of interventions. Psychology, Health & Medicine, 16(5), 493–527.
Smith, L. R., Earnshaw, V. A., Copenhaver, M. M., & Cunningham, C. O. (2016). Substance use stigma: Reliability and validity of a theory-based scale for substance- using populations. Drug and Alcohol Dependence, 162, 34–43.
Stein, M. D., Solomon, D. A., Herman, D. S., Anderson, B. J., & Miller, I. (2003). Depression severity and drug injection HIV risk behaviors. The American Journal of Psychiatry, 160(9), 1659–1662. https://doi.org/10.1176/appi.ajp.160.9.1659
Tempalski, B., Williams, L. D., Kolak, M., Ompad, D. C., Koschinsky, J., & McLafferty, S. L. (2022). Conceptualizing the socio-built environment: An expanded theoretical framework to promote a better understanding of risk for nonmedical opioid overdose outcomes in urban and non-urban settings. Journal of Urban Health, 99(4), 701–716.
U.S. Department of Health and Human Services. (2022). Major depression. National Institute of Mental Health. https://www.nimh.nih.gov/health/statistics/major-depression
von Hippel, C., Brener, L., & Horwitz, R. (2018). Implicit and explicit internalized stigma: Relationship with risky behaviors, psychosocial functioning and healthcare access among people who inject drugs. Addictive Behaviors, 76, 305–311.
Wang, L., Wang, Q., Davis, P. B., Volkow, N. D., & Xu, R. (2022). Increased risk for COVID-19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021. World Psychiatry, 21(1), 124–132.
Williams, L. D., Aber, J. L., & SIZE Research Group. (2019). The multilevel relationships of HIV-related stigma to child and caregiver mental health among HIV-affected households in South Africa. American Journal of Community Psychology, 63(1-2), 3–16.
Williams, L. D., Lee, E., Latkin, C., Mackesy-Amiti, M. E., Kaufmann, M., Copulsky, E., Kaplan, C., & Boodram, B. (2022). Economic challenges and behavioral and mental health risks for overdose during the COVID-19 pandemic among people who inject drugs. International Journal of Environmental Research and Public Health, 19(9), 5351.
Williams, L. D., Mackesy-Amiti, M. E., Latkin, C., & Boodram, B. (2021). Drug use-related stigma, safer injection norms, and hepatitis C infection among a network-based sample of young people who inject drugs. Drug and Alcohol Dependence, 221, 108626.
Wilson, J. M., Weiss, A., & Shook, N. J. (2020). Mindfulness, self-compassion, and savoring: Factors that explain the relation between perceived social support and well-being. Personality and Individual Differences, 152, 109568.
Zwick, J., Appleseth, H., & Arndt, S. (2020). Stigma: How it affects the substance use disorder patient. Substance Abuse Treatment, Prevention, and Policy, 15, 1–4.
Funding
Research described in this manuscript was supported by the National Institute on Drug Abuse under award number R01DA043484 (Contextual Risk Factors for Hepatitis C among Young Persons who Inject Drugs).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics Approval
The authors declare that they have obtained ethics approval from the Institutional Review Board at the University of Illinois at Chicago (Protocol # 2017-0388) where the research entailed animal or human participation.
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Williams, L.D., Nowlin, J., Rodriguez, W.A. et al. Testing the Relationships Between Multiple Domains of Substance Use-Related Stigma and Depression Among a Sample of Young (18–30-Year-Old) People Who Inject Drugs in the Greater Chicago Area. Int J Ment Health Addiction (2023). https://doi.org/10.1007/s11469-023-01155-2
Accepted:
Published:
DOI: https://doi.org/10.1007/s11469-023-01155-2